ARGX vs PHAR: Side-by-Side Comparison
Compare Argen X SE (ARGX) and Pharming Group N.V. (PHAR) side by side: market cap USD 58.44B vs USD 965.83M. Financials, growth and model signals on Bullrun.
| Metric | ARGX | PHAR |
|---|---|---|
| Company | Argen X SE | Pharming Group N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 58.44B | USD 965.83M |
| P/E ratio | — | 79.9 |
| Dividend yield | — | — |
| Valuation model | — | 37.6% overvalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |